Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma
Cancer Immunotherapy: 2016 vs 2026
Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer
10 Must-Read Posts In GU Oncology This Week
ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month
Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC
Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04
The AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer will take place from December 6–8, 2026, at the Hyatt Regency Austin in Austin, Texas, USA. Organized by the American Association for Cancer Research (AACR), the conference will bring together basic scientists, physician-scientists, and industry professionals to discuss […]
